About Ubidyne
Ubidyne is a company based in Ulm (Germany) founded in 2005 was acquired by Kathrein Group in June 2013. Ubidyne has raised $48.8 million across 2 funding rounds from investors including Accel, Gimv and Kathrein Group. The company has 5 employees as of December 31, 2017. Ubidyne operates in a competitive market with competitors including Abracon, Fractus, SkyCross, InnerWireless and Airwavz solutions, among others.
- Headquarter Ulm, Germany
- Employees 5 as on 31 Dec, 2017
-
Sectors
Telecommunications
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Carmudi Gmbh
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$48.8 M (USD)
in 2 rounds
-
Latest Funding Round
$14.4 M (USD), Series B
Aug 20, 2009
-
Investors
Accel
& 5 more
-
Employee Count
5
as on Dec 31, 2017
-
Acquired by
Kathrein Group
(Jun 01, 2013)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Ubidyne
Ubidyne has successfully raised a total of $48.8M across 2 strategic funding rounds. The most recent funding activity was a Series B round of $14.4 million completed in August 2009. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Ubidyne
Ubidyne has secured backing from 6 investors, including venture fund and institutional investors. Prominent investors backing the company include Accel, Gimv and Kathrein Group.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity firm
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked | |
|
Capital is invested in life science innovations for healthcare transformation.
|
Locked | Locked | Locked |
Investor details for Ubidyne
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Ubidyne
Investment portfolio details for Ubidyne
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Ubidyne
Detailed financials for Ubidyne
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Ubidyne Comparisons
Peer comparison for Ubidyne
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Ubidyne
Ubidyne operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Abracon, Fractus, SkyCross, InnerWireless and Airwavz solutions, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Electrical circuit components including timing and power solutions are manufactured.
|
|
| Locked | Locked | Locked |
Antennas equipment provider
|
|
| Locked | Locked | Locked |
Antenna and RF solutions are designed and manufactured by SkyCross.
|
|
| Locked | Locked | Locked |
In-building wireless coverage is delivered via antennas and distributed systems.
|
|
| Locked | Locked | Locked |
DAS, Small Cell and Het-Net solutions
|
|
| Locked | Locked | Locked |
DAS technology for in-building wireless coverage is provided.
|
Detailed competitors of Ubidyne
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Ubidyne
Complete news archive for Ubidyne
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ubidyne
Ubidyne was founded in 2005 and raised its 1st funding round 3 years after it was founded.
Ubidyne is headquartered in Ulm, Germany. It is registered at Ulm, Baden-wurttemberg, Germany.
Ubidyne is a funded company, having raised a total of $48.8M across 2 funding rounds to date.
As of Dec 31, 2017, the latest employee count at Ubidyne is 5.
Ubidyne was founded in 2005 in Ulm, Germany, and operated within the wireless communications sector. Antenna-embedded radio systems for base stations were manufactured, featuring integrated digital radio frequency units within antenna housings. Energy consumption was reduced, deployment was simplified, and network coverage with capacity was enhanced through these systems. Acquisition by Kathrein AG occurred in 2013.
Ubidyne's top competitors include Abracon, Fractus and Airwavz solutions.
Ubidyne has 6 investors. Key investors include Accel, Gimv, Kathrein Group, BayTech Venture Capital, and TVM Capital Life Science.